1. Antioxidant Properties and Aldehyde Reactivity of PD-L1 Targeted Aryl-Pyrazolone Anticancer Agents
- Author
-
Leleu, N. (Natascha), Regnault, R. (Romain), Ahouari, H. (Hania), Le Biannic, R. (Raphael), Kouach, M. (Mostafa), Klupsch, F. (Frederique), Magnez, R. (Romain), Vezin, H. (Herve), Thuru, X. (Xavier), Bailly, C. (Christian), Goossens, J-F. (Jean-Francois), MILLET, R. (Régis), Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Laboratoire Avancé de Spectroscopie pour les Intéractions la Réactivité et l'Environnement - UMR 8516 (LASIRE), Institut de Chimie du CNRS (INC)-Université de Lille-Centre National de la Recherche Scientifique (CNRS), Miniaturisation pour la Synthèse, l’Analyse et la Protéomique - UAR 3290 (MSAP), Université de Lille-Centre National de la Recherche Scientifique (CNRS), Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 (CANTHER), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Oncowitan [Wasquehal], Université de Lille, LillOA, Université de Lille, CNRS, Lille Inflammation Research International Center - U 995 [LIRIC], 495476|||Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA], Laboratoire Avancé de Spectroscopie pour les Intéractions la Réactivité et l'Environnement - UMR 8516 [LASIRE], Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365, Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER) - UMR 9020 - UMR 1277, Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA], and Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
- Subjects
PD-L1 ,Aldehydes ,antioxidant ,edaravone ,Programmed Cell Death 1 Receptor ,Organic Chemistry ,pyrazolone ,Pharmaceutical Science ,Antineoplastic Agents ,Antioxidants ,B7-H1 Antigen ,Analytical Chemistry ,aldehyde reactivity ,[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistry ,drug adducts ,[CHIM.THEO] Chemical Sciences/Theoretical and/or physical chemistry ,Chemistry (miscellaneous) ,cancer ,Drug Discovery ,Molecular Medicine ,Fluorouracil ,Pyrazolones ,Physical and Theoretical Chemistry - Abstract
International audience; Small molecules targeting the PD-1/PD-L1 checkpoint are actively searched to complement the anticancer arsenal. Different molecular scaffolds have been reported, including phenyl-pyrazolone derivatives which potently inhibit binding of PD-L1 to PD-1. These molecules are structurally close to antioxidant drug edaravone (EDA) used to treat amyotrophic lateral sclerosis. For this reason, we investigated the capacity of five PD-L1-binding phenyl-pyrazolone compounds (1–5) to scavenge the formation of oxygen free radicals using electron spin resonance spectroscopy with DPPH/DMPO probes. In addition, the reactivity of the compounds toward the oxidized base 5-formyluracil (5fU) was assessed using chromatography coupled to mass spectrometry and photodiode array detectors. The data revealed that the phenyl-pyrazolone derivatives display antioxidant properties and exhibit a variable reactivity toward 5fU. Compound 2 with a N-dichlorophenyl-pyrazolone moiety cumulates the three properties, being a potent PD-L1 binder, a robust antioxidant and an aldehyde-reactive compound. On the opposite, the adamantane derivative 5 is a potent PD-L1 binding with a reduced antioxidant potential and no aldehyde reactivity. The nature of the substituent on the phenyl-pyrazolone core modulates the antioxidant capacity and reactivity toward aromatic aldehydes. The molecular signature of the compound can be adapted at will, to confer additional properties to these PD-L1 binders.
- Published
- 2022